Literature DB >> 25042819

A new kind of labyrinth-like capillary is responsible for leakage from human choroidal neovascular endothelium, as investigated by high-resolution electron microscopy.

Ulrich Schraermeyer1, Sylvie Julien, Antje Biesemeier, Karl Ulrich Bartz-Schmidt, Hartwig Wolburg.   

Abstract

PURPOSE: This study reports the clinicopathologic findings of leaky sites in pathological vessels after submacular removal of choroidal neovascular membranes (CNV). As the site that causes fluid exudation from neovascular vessels is unknown, specific attention was focused on the formation of fenestrations, cellular junctions, and morphologic alteration which can cause endothelial leakage.
METHODS: Choroidal neovascular membranes of 15 patients who underwent submacular surgery for CNV were investigated. Five patients received bevacizumab treatment before surgery, and another five received photodynamic therapy before surgery. The remaining five did not receive any other treatment before surgery. All membranes were embedded for transmission electron microscopy. CNVs were analyzed for pathological cell-to-cell connections, fenestrations, or other pathological conditions which can cause leakage of plasma.
RESULTS: The morphology of the newly formed blood channels was very variable, and in principle was not different in treated and untreated patients. The sources of leakage in neovascular choroidal vessels were caused by insufficient endothelial cell connections and by capillaries with microvillar projections into the vessel lumen which blocked cellular perfusion but still allowed the flow of plasma. Fenestrations were only infrequently observed.
CONCLUSIONS: A newly discovered type of pathological capillary, called a labyrinth capillary, is very likely responsible for the permanent leakage of fluid. Due to the small vessel lumen, thrombocytes cannot enter these capillaries to close the leakages. Fenestrations did not appear to play a significant role in vascular leakiness.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25042819     DOI: 10.1007/s00417-014-2733-0

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  33 in total

1.  Surgical excision of subfoveal neovascular membranes in age-related macular degeneration.

Authors:  H M Lambert; A Capone; T M Aaberg; P Sternberg; B A Mandell; P F Lopez
Journal:  Am J Ophthalmol       Date:  1992-03-15       Impact factor: 5.258

Review 2.  Choroidal neovascularization.

Authors:  Hans E Grossniklaus; W Richard Green
Journal:  Am J Ophthalmol       Date:  2004-03       Impact factor: 5.258

3.  Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration.

Authors:  E de Juan; R Machemer
Journal:  Am J Ophthalmol       Date:  1988-01-15       Impact factor: 5.258

4.  Indocyanine green and fluorescein angiography of surgically excised macular choroidal neovascularizations: correlations with histopathologic and ultrastructural findings.

Authors:  G Trabucchi; R Brancato; V De Molfetta; M Verdi; A Pece; U Introini; P Avanza; G Modorati; P Airaghi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-05       Impact factor: 3.117

5.  Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy.

Authors:  Darius M Moshfeghi; Peter K Kaiser; Hans E Grossniklaus; Paul Sternberg; Jonathan E Sears; Mark W Johnson; Norman Ratliff; Andre Branco; Mark S Blumenkranz; Hilel Lewis
Journal:  Am J Ophthalmol       Date:  2003-03       Impact factor: 5.258

Review 6.  A systematic review on the effect of bevacizumab in exudative age-related macular degeneration.

Authors:  Jan S A G Schouten; Ellen C La Heij; Carroll A B Webers; Igor J Lundqvist; Fred Hendrikse
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-10-09       Impact factor: 3.117

7.  [The effect of bevacizumab on the ultrastructure of choroidal neovascular membranes in patients with age-related macular degeneration (AMD)].

Authors:  C Vidinova; N Vidinov
Journal:  Klin Monbl Augenheilkd       Date:  2009-06-08       Impact factor: 0.700

8.  Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab.

Authors:  Swaantje Peters; Peter Heiduschka; Sylvie Julien; Focke Ziemssen; Heike Fietz; Karl Ulrich Bartz-Schmidt; Ulrich Schraermeyer
Journal:  Am J Ophthalmol       Date:  2007-04-23       Impact factor: 5.258

9.  Comparison of outcomes after switching treatment from intravitreal bevacizumab to ranibizumab in neovascular age-related macular degeneration.

Authors:  Jerrod S Kent; Yiannis Iordanous; Alex Mao; Anne-Marie Powell; Shefalee Shukla Kent; Tom G Sheidow
Journal:  Can J Ophthalmol       Date:  2012-04       Impact factor: 1.882

10.  Effects of bevacizumab in retina and choroid after intravitreal injection into monkey eyes.

Authors:  Ulrich Schraermeyer; Sylvie Julien
Journal:  Expert Opin Biol Ther       Date:  2012-11-29       Impact factor: 4.388

View more
  3 in total

1.  Effects of intravitreally injected Fc fragment on rat eyes.

Authors:  Tatjana Taubitz; Laura-Pia Steinbrenner; Alexander V Tschulakow; Antje Biesemeier; Sylvie Julien-Schraermeyer; Ulrich Schraermeyer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-10-17       Impact factor: 3.117

2.  Pigment Epithelium-Derived Factor Protects Retinal Neural Cells and Prevents Pathological Angiogenesis in an Ex Vivo Ischemia Model.

Authors:  Lei Xi; Marina Tikhonovich; Antje Biesemeier; Sylvie Julien-Schraermeyer; Ulrich Schraermeyer; Alexander V Tschulakow
Journal:  Oxid Med Cell Longev       Date:  2022-08-05       Impact factor: 7.310

3.  A new rat model of treatment-naive quiescent choroidal neovascularization induced by human VEGF165 overexpression.

Authors:  Shan Liu; Antje K Biesemeier; Alexander V Tschulakow; Harsh V Thakkar; Sylvie Julien-Schraermeyer; Ulrich Schraermeyer
Journal:  Biol Open       Date:  2020-06-11       Impact factor: 2.422

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.